{{Rsnum
|rsid=3788205
|Gene=SLC19A1
|Chromosome=21
|position=45544464
|Orientation=plus
|GMAF=0.2052
|Gene_s=SLC19A1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 51.3 | 41.6 | 7.1
| HCB | 51.8 | 43.1 | 5.1
| JPT | 68.1 | 27.4 | 4.4
| YRI | 98.6 | 1.4 | 0.0
| ASW | 77.2 | 22.8 | 0.0
| CHB | 51.8 | 43.1 | 5.1
| CHD | 63.3 | 33.0 | 3.7
| GIH | 50.5 | 46.5 | 3.0
| LWK | 99.1 | 0.9 | 0.0
| MEX | 44.8 | 41.4 | 13.8
| MKK | 92.3 | 7.7 | 0.0
| TSI | 47.1 | 42.2 | 10.8
| HapMapRevision=28
}}{{PMID Auto
|PMID=20871623
|Title=Genetic analysis of six SNPs in candidate genes associated with high cross-race risk of development of thoracic aortic aneurysms and dissections in Chinese Han population
}}

{{PMID Auto
|PMID=22186609
|Title=Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}